Myasthenia gravis patient and physician opinions about immunosuppressant reduction.
Michael K HehirAnna Rostedt PungaEmma CiafaloniPublished in: Muscle & nerve (2020)
Patients and physicians favor considering IS dose reduction but are also concerned about potential negative sequelae.